Engchem Life Sciences and Korea Institute of Radiological & Medical Sciences to Jointly Develop Treatment for Radiation-Induced Dermatitis
Expanding Collaboration in Radiological Life Sciences
Building on Previous GI-ARS Joint Research Experience
Engchem Life Sciences announced on August 4 that it has signed a memorandum of understanding (MOU) for joint research collaboration with the Korea Institute of Radiological & Medical Sciences to develop a treatment for radiation-induced dermatitis.
The two institutions will review the feasibility of developing a treatment for radiation-induced dermatitis and will pursue joint research initiatives. Engchem Life Sciences will be responsible for establishing the development strategy, while the Korea Institute of Radiological & Medical Sciences will conduct efficacy studies, with both parties planning to gradually explore further collaborative development steps.
Radiation-induced dermatitis is a common side effect experienced by cancer patients undergoing radiation therapy, which can lead to delays or interruptions in treatment. Currently, care is focused on symptom relief using moisturizers and topical steroids, but there is a significant unmet medical need for new therapeutics in this area.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
This collaboration expands the scope of research into the field of radiation therapy side effects, building on the cooperative relationship the two institutions have established through their previous joint research on gastrointestinal acute radiation syndrome (GI-ARS).
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.